AskTheDate.com
Back to calendar

Coherus Oncology, Inc. (CHRS) Earnings

CHRS reports earnings on Monday, November 9, 2026

earnings report
November 9, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.22
Actual EPS: $-0.22
EPS surprise: 12.00%
Company overview
Market Cap$208.6M
PriceUSD 1.35
EPS (TTM)-1.02
52-week high2.62
52-week low1.09
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees147
Buy me a coffee